iSpecimen Inc is advancing its $200 million crypto treasury plan and plans to purchase SOL.

Jinse Finance reported that biosample procurement company iSpecimen Inc. (ISPC) stated it is evaluating investment proposals from several cryptocurrency companies to advance its $200 million crypto treasury plan. The company is simultaneously progressing with a treasury project based on SOL, intending to purchase SOL through over-the-counter transactions, including acquiring locked SOL with transfer restrictions. iSpecimen Inc. CEO Robert Lim said that while acquiring locked SOL is attractive, they are still exploring other opportunities. iSpecimen plans to adopt a buy-and-hold strategy to fund its crypto treasury through regular fundraising and will stake SOL to generate returns.